Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective

Metabolism: Clinical and Experimental
R R Holman

Abstract

The United Kingdom Prospective Diabetes Study shows sulfonylureas to be an effective first-line therapy for people with type 2 diabetes mellitus. The durability of the glycemic control obtained is dependent on the degree to which beta-cell function can be maintained, but sulfonylureas appear neither to increase nor to decrease the underlying rate of loss of beta-cell function. As sulfonylureas act by enhancing insulin secretion, they are probably best used close to the time when diabetes is diagnosed when beta-cell function is at its greatest and their utility can be extended by judicious use in combination with agents that improve glycemia by different modes of action, including insulin.

References

Jun 25, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·UNKNOWN ADVANCE Collaborative Group

❮ Previous
Next ❯

Citations

Jan 30, 2013·Nature Reviews. Nephrology·Colleen Flynn, George L Bakris
Aug 26, 2011·Metabolic Syndrome and Related Disorders·Arthur L M SwislockiRobert H Noth
Oct 13, 2009·Diabetes, Obesity & Metabolism·G LeibowitzE Cerasi
Apr 13, 2010·Diabetes, Obesity & Metabolism·Kevin Niswender
Mar 21, 2012·Diabetes, Obesity & Metabolism·M A Nauck
Apr 7, 2011·Journal of Diabetes Investigation·Gil LeibowitzErol Cerasi
Dec 7, 2007·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Allan Vaag, Søren S Lund
May 23, 2014·Cardiovascular Journal of Africa·Poobalan NaidooSelvarajah Saman
May 31, 2012·ISRN Endocrinology·Man-Wo Tsang
Mar 21, 2007·Expert Opinion on Investigational Drugs·Carolyn F Deacon
Aug 2, 2011·Clinical Therapeutics·Deanna S KaniaZachary A Weber
Feb 17, 2009·Metabolism: Clinical and Experimental·Akiko Matsuyama-YokonoMasayuki Shibasaki
Nov 27, 2007·Clinical Therapeutics·Aaron Vinik
Nov 6, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·V T T HuyenC G Ostenson
Dec 3, 2014·The Medical Clinics of North America·Stephen A Brietzke
Oct 2, 2007·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·John P H WildingUNKNOWN GALLANT 7 Study Group
Jun 14, 2018·The Journal of Clinical Endocrinology and Metabolism·Christine M Burt SolorzanoChristopher R McCartney
Apr 2, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·James A BlackRebecca K Simmons
Feb 22, 2008·Cardiovascular Drugs and Therapy·Partha Kar, Richard I G Holt
Dec 11, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paul ArnoutsWim van Biesen
Jul 25, 2019·Journal of Diabetes Investigation·Atsushi SatomuraAkira Shimada
Jan 1, 2007·Expert Review of Endocrinology & Metabolism·Antonella Maffei, Paul E Harris
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity
Feb 15, 2008·Diabetes Care·Massimo Massi-Benedetti, Marco Orsini-Federici

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.